347 related articles for article (PubMed ID: 28159833)
1. SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.
Fahey CC; Davis IJ
Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159833
[TBL] [Abstract][Full Text] [Related]
2. Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation.
Hacker KE; Fahey CC; Shinsky SA; Chiang YJ; DiFiore JV; Jha DK; Vo AH; Shavit JA; Davis IJ; Strahl BD; Rathmell WK
J Biol Chem; 2016 Sep; 291(40):21283-21295. PubMed ID: 27528607
[TBL] [Abstract][Full Text] [Related]
3. Shaping the cellular landscape with Set2/SETD2 methylation.
McDaniel SL; Strahl BD
Cell Mol Life Sci; 2017 Sep; 74(18):3317-3334. PubMed ID: 28386724
[TBL] [Abstract][Full Text] [Related]
4. SETD2-dependent H3K36me3 plays a critical role in epigenetic regulation of the HPV31 life cycle.
Gautam D; Johnson BA; Mac M; Moody CA
PLoS Pathog; 2018 Oct; 14(10):e1007367. PubMed ID: 30312361
[TBL] [Abstract][Full Text] [Related]
5. SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer.
Kumari S; Muthusamy S
Eur J Cancer Prev; 2020 Nov; 29(6):556-564. PubMed ID: 33021769
[TBL] [Abstract][Full Text] [Related]
6. A New Chromatin-Cytoskeleton Link in Cancer.
Giaccia AJ
Mol Cancer Res; 2016 Dec; 14(12):1173-1175. PubMed ID: 27528705
[TBL] [Abstract][Full Text] [Related]
7. Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36.
de Almeida SF; Grosso AR; Koch F; Fenouil R; Carvalho S; Andrade J; Levezinho H; Gut M; Eick D; Gut I; Andrau JC; Ferrier P; Carmo-Fonseca M
Nat Struct Mol Biol; 2011 Jul; 18(9):977-83. PubMed ID: 21792193
[TBL] [Abstract][Full Text] [Related]
8. The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3).
Berthelet J; Michail C; Bui LC; Le Coadou L; Sirri V; Wang L; Dulphy N; Dupret JM; Chomienne C; Guidez F; Rodrigues-Lima F
Mol Pharmacol; 2021 Sep; 100(3):283-294. PubMed ID: 34266924
[TBL] [Abstract][Full Text] [Related]
9. SETD2, an epigenetic tumor suppressor: a focused review on GI tumor.
Hu M; Hu M; Zhang Q; Lai J; Liu X
Front Biosci (Landmark Ed); 2020 Jan; 25(4):781-797. PubMed ID: 31585917
[TBL] [Abstract][Full Text] [Related]
10. SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability.
Pfister SX; Ahrabi S; Zalmas LP; Sarkar S; Aymard F; Bachrati CZ; Helleday T; Legube G; La Thangue NB; Porter AC; Humphrey TC
Cell Rep; 2014 Jun; 7(6):2006-18. PubMed ID: 24931610
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms in governing genomic stability and tumor suppression by the SETD2 H3K36 methyltransferase.
Lam UTF; Chen ES
Int J Biochem Cell Biol; 2022 Mar; 144():106155. PubMed ID: 34990836
[TBL] [Abstract][Full Text] [Related]
12. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas.
Fontebasso AM; Schwartzentruber J; Khuong-Quang DA; Liu XY; Sturm D; Korshunov A; Jones DT; Witt H; Kool M; Albrecht S; Fleming A; Hadjadj D; Busche S; Lepage P; Montpetit A; Staffa A; Gerges N; Zakrzewska M; Zakrzewski K; Liberski PP; Hauser P; Garami M; Klekner A; Bognar L; Zadeh G; Faury D; Pfister SM; Jabado N; Majewski J
Acta Neuropathol; 2013 May; 125(5):659-69. PubMed ID: 23417712
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants for α-tubulin methylation by SETD2.
Kearns S; Mason FM; Rathmell WK; Park IY; Walker C; Verhey KJ; Cianfrocco MA
J Biol Chem; 2021 Jul; 297(1):100898. PubMed ID: 34157286
[TBL] [Abstract][Full Text] [Related]
14. SETD2 reduction adversely affects the development of mouse early embryos.
Li C; Huang Z; Gu L
J Cell Biochem; 2020 Jan; 121(1):797-803. PubMed ID: 31407364
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between the H3K36me3 and H4K16ac histone epigenetic marks in DNA double-strand break repair.
Li L; Wang Y
J Biol Chem; 2017 Jul; 292(28):11951-11959. PubMed ID: 28546430
[TBL] [Abstract][Full Text] [Related]
16. Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3-MutSα interaction.
Fang J; Huang Y; Mao G; Yang S; Rennert G; Gu L; Li H; Li GM
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9598-9603. PubMed ID: 30181289
[TBL] [Abstract][Full Text] [Related]
17. The SETD2 Methyltransferase Supports Productive HPV31 Replication through the LEDGF/CtIP/Rad51 Pathway.
Mac M; DeVico BM; Raspanti SM; Moody CA
J Virol; 2023 May; 97(5):e0020123. PubMed ID: 37154769
[TBL] [Abstract][Full Text] [Related]
18. Roles of SETD2 in Leukemia-Transcription, DNA-Damage, and Beyond.
Skucha A; Ebner J; Grebien F
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818762
[TBL] [Abstract][Full Text] [Related]
19. Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2.
Eram MS; Kuznetsova E; Li F; Lima-Fernandes E; Kennedy S; Chau I; Arrowsmith CH; Schapira M; Vedadi M
Biochim Biophys Acta; 2015 Sep; 1850(9):1842-8. PubMed ID: 26002201
[TBL] [Abstract][Full Text] [Related]
20. The Iws1:Spt6:CTD complex controls cotranscriptional mRNA biosynthesis and HYPB/Setd2-mediated histone H3K36 methylation.
Yoh SM; Lucas JS; Jones KA
Genes Dev; 2008 Dec; 22(24):3422-34. PubMed ID: 19141475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
